Session 9 from the 2024 World Sepsis Congress Spotlight is now available on YouTube (embedded above) and as a Podcast on Apple Podcasts (search for World Sepsis Congress in your favorite podcast app).

---

Session 9: Challenges and Solutions for Early Recognition and Treatment of Sepsis

ARCS: Understanding Risk Factors for Delayed Presentation and Care of Sepsis Patients in DRC, Nigeria, and Sierra Leone
Patrick de Marie Katoto, Catholic University of Bukavu, DRC

Sepsis Check – A Preclinical Checklist for Early Detection and Education
Wiltrud Abels, Charité – Universitätsmedizin Berlin, Germany

Early Resuscitation of Septic Shock in the ED – Which Perfusion Parameters for Target Resuscitation?
Glenn Hernández Poblete, Pontifical Catholic University of Chile, Chile

Sepsis in Brazilian Emergency Departments: A Prospective Multicenter Observational Study
Flavia Machado, Latin American Sepsis Institute, Brazil

Smart Triage: Electronic Support for Early Recognition and Triage of Severely Ill Patients in Ugandan Emergency Departments
Mark Ansermino, BC Children’s Hospital, Canada

Closing Remarks
Michael Wong, Physician-Patient Alliance for Health & Safety, United States of America

---

This was the final session of the 2024 WSC Spotlight – all sessions and presentations are now available to watch/listen to.

---

Thank you for your interest in the 2024 WSC Spotlight over the last couple of weeks. World Sepsis Congress will return with the 5th World Sepsis Congress in April 2025.

Thank you so much for participating in the 2024 WSC Spotlight in April – it was our pleasure having all of you.

12,230 people from 185 countries registered to participate, which is astonishing. 65% of our audience joined from low- and middle-income countries – indicating that sepsis is a true global health threat, not recognizing borders or the perceived quality of a healthcare system. This truly highlights our mission with World Sepsis Congress – to bring knowledge about sepsis to all parts of the world.

We were particularly excited with your feedback – it is inspirational to hear how much you enjoyed the congress. Please click through the full report above or download it as a PDF below. Feel free to share it with colleagues, friends, family members, and beyond.

8 of the 9 sessions are already available on YouTube, as a Podcast on Apple Podcasts, and on the congress website, with session 9 being released tomorrow, July 2. CME Credits are available via the PPAHS, our partner organization.

Thanks for your interest over the last weeks – we can’t wait to return with the 5th World Sepsis Congress in April 2025.

To support or to contribute to World Sepsis Congress in the future, please contact us.

Session 8 from the 2024 World Sepsis Congress Spotlight is now available on YouTube (embedded above) and as a Podcast on Apple Podcasts (search for World Sepsis Congress in your favorite podcast app).

---

Session 8: Personalized Approaches to Sepsis Management

TREM-1 Pathway
Bruno Francois, Dupuytren University Hospital, France

ARDS: Room for Precision Treatment?
Carolyn Calfee, University of California, San Francisco Medical Center, United States of America

Modulation of Complement
Alexander Vlaar, Amsterdam UMC, The Netherlands

Macrolides for Community-Acquired Pneumonia
Michael Niederman, Weill Cornell Medicine, United States of America

Reversal of Immunoparalysis
Sara Cajander, Örebro University, Hospital, Sweden

---

Sessions are released weekly on Tuesdays. The next and final session will be ‘Challenges and Solutions for Early Recognition and Treatment of Sepsis’ on July 2, 2024.

You can already subscribe on either platform to be automatically notified once new sessions are available.

---

Full Release Schedule

• S1: Opening Session: The Renewed Global Agenda for Sepsis – Tuesday, May 7, 2024

• S2: The Need for Early Diagnosis and Treatment of Sepsis in Surgical Patients – Tuesday, May 14, 2024

• S3: Data, AI, and Predictive Modeling in Sepsis – Tuesday, May 21, 2024

• S4: How Does Hypervolemia Increase the Mortality Risk in Sepsis? – Tuesday, May 28, 2024

• S5: The Role of Biomarkers in the Early Detection of Sepsis – Tuesday, June 4, 2024

• S6: Detecting Sepsis in the Ventilated Patient – Tuesday, June 11, 2024

• S7: Closing the Needs in Pediatric Sepsis – Tuesday, June 18, 2024

• S8: Personalized Approaches to Sepsis Management – Tuesday, June 25, 2024

• S9: Challenges and Solutions for Early Recognition and Treatment of Sepsis – Tuesday, July 2, 2024

---

Dr. Mariam Jashi, CEO of the Global Sepsis Alliance joined the distinguished panelists of the First Global Self-Care Summit held in parallel with the 77th Session of the World Health Assembly in Geneva.

The summit brought together high-level policymakers and global health experts, including Dr. Mary Munive Angermüller, Vice-President and Minister of Health of Costa Rica as the keynote speaker and senior representatives of the Ministries of Health of Egypt and Malawi as co-hosts of the event as part of their ongoing work to elevate self-care in national health policies. Ministerial delegations from Guatemala, Belize, Panama, and El Salvador also attended and contributed to the discussions on how to integrate self-care into wider health plans in the Latin American region.

Upon invitation of Judy Stenmark, the Director General of the Global Self-Care Federation, Dr, Jashi spoke on behalf of the UNITE Parliamentarians Network and the Global Sepsis Alliance and emphasized the legislative and executive approaches how to integrate self-care into public health policies. She shared the stage with Dr Manjulaa Narasimhan, Acting Unit Head for Sexual Health and well-being at the World Health Organization; Professor Iain Chapple from the Institute Clinical Studies, University of Birmingham; Ellos Lodzeni - Chair, International Alliance of Patients’ Organizations (IAPO) and Wendy Olayiwola, President, Nigerian Nurses Association UK and Professional Midwifery Advocate.

At the follow-up bilateral discussions after the summit, Mariam Jashi and Judy Stenmark discussed prospects of continued collaboration between the UNITE Parliamentarian Network, the Global Sepsis Alliance, and the Global Self-Care Foundation, including how to integrate self-care in Universal Health Coverage policies and initiatives, and expressed hopes for future collaboration for the advancement of the reinvigorated global agenda for sepsis.

Session 7 from the 2024 World Sepsis Congress Spotlight is now available on YouTube (embedded above) and as a Podcast on Apple Podcasts (search for World Sepsis Congress in your favorite podcast app).

---

Session 7: Closing the Needs in Pediatric Sepsis

The Phoenix Criteria – How We Got Here
Luregn Schlapbach, University Children’s Hospital Zurich, Switzerland

The Phoenix Criteria Revealed
Daniela de Souza, Global Sepsis Alliance, Brazil

Personalized Care Post-Discharge for Sepsis
Matthew Wiens, University of British Columbia, Canada

The Latest Update on Fluid Therapy in Sepsis
Jhuma Sankar, All India Institute of Medical Sciences, India

The Advances of the WHO in Pediatric Sepsis Initiatives
Emilie Calvello-Hynes, World Health Organization, Switzerland

Empiric Treatment of Neonatal Sepsis: Progress to Date
Sally Ellis, Global Antibiotic Research & Development Partnership, Switzerland

---

Sessions are released weekly on Tuesdays. The next session will be ‘Personalized Approaches to Sepsis Management’ on June 25, 2024.

You can already subscribe on either platform to be automatically notified once new sessions are available.

---

Full Release Schedule

• S1: Opening Session: The Renewed Global Agenda for Sepsis – Tuesday, May 7, 2024

• S2: The Need for Early Diagnosis and Treatment of Sepsis in Surgical Patients – Tuesday, May 14, 2024

• S3: Data, AI, and Predictive Modeling in Sepsis – Tuesday, May 21, 2024

• S4: How Does Hypervolemia Increase the Mortality Risk in Sepsis? – Tuesday, May 28, 2024

• S5: The Role of Biomarkers in the Early Detection of Sepsis – Tuesday, June 4, 2024

• S6: Detecting Sepsis in the Ventilated Patient – Tuesday, June 11, 2024

• S7: Closing the Needs in Pediatric Sepsis – Tuesday, June 18, 2024

• S8: Personalized Approaches to Sepsis Management – Tuesday, June 25, 2024

• S9: Challenges and Solutions for Early Recognition and Treatment of Sepsis – Tuesday, July 2, 2024

---

I came back home from a long trip and met one of my young daughters looking so lean and slim, and I was like, are you growing taller or just slimming to fashion? Her siblings said, “No Mum, she had been ill with a fever that is not responding to treatment.” My first thought was typhoid fever, because this was quite prevalent in our areas, with the lack of clean drinking water and other environmental issues.

So, off to the hospital, we went to see a doctor. After laying all her complaints, and after examination the doctor ordered some laboratory investigations which included Blood Culture. Meanwhile, she was given anti-malarial medications, antibiotics, and fluids (intravenous infusion) as she was unable to eat anything, and was dehydrated. Despite these measures, her condition worsened. She became lethargic to the point of needing support to walk. Suddenly, a realization hit me, “Could this be sepsis?”

Incidentally, all these took place at the weekend, when there’s this lackadaisical attitude and manpower shortages in all departments. The laboratory was working half–capacity, and no scientist on the ground to give us a preliminary result. I thought I could not wait until Monday before commencing her proper treatment to manage what was unfolding in front of us by the second.

I promptly returned her to the doctor and recommended starting her on broad-spectrum antibiotics to cover a wide range of possible infections. We also administered supplemental oxygen because her oxygen levels were below normal.

There was an issue with the hospital’s stock of antibiotics, so my husband had to buy the prescribed antibiotic from the pharmacy across the street. When he initially brought back the medication, I realized it was not the specific antibiotic the doctor had prescribed for her condition. I pleaded with him to go back and buy the exact one prescribed because this was a life-and-death situation, and we couldn't take any chances. 

At this point, I was becoming so anxious and getting worried that I might lose my daughter if proper care was not taken. All the family members gave the spiritual and psychological support that was needed.

Fortunately, by the second day of receiving the antibiotic, she started to recover gradually, gaining her strength and appetite, her fever dropped and at that moment, I knew we had won the battle. My sweet sixteen-year-old girl was back on her feet, and is a “Sepsis Survivor”!

Sepsis presented itself at my doorstep when I least expected it, being an advocate and a sepsis Champion, I am glad that I was able to recognize it early and gave the right drug at an early stage to combat it. In doing so, I stopped sepsis and saved a life!

Halima Salisu-Kabara

Mother to the Sepsis Survivor

---

The article above was written by Halima Salisu Kabara, one of our Global Sepsis Alliance Board Members, and is shared with her explicit consent. The views in the article do not necessarily represent those of the Global Sepsis Alliance. They are not intended or implied to be a substitute for professional medical advice. The whole team here at the Global Sepsis Alliance and World Sepsis Day wishes to thank her for sharing her daughter’s story and for fighting to raise awareness for sepsis.

Session 6 from the 2024 World Sepsis Congress Spotlight is now available on YouTube (embedded above) and as a Podcast on Apple Podcasts (search for World Sepsis Congress in your favorite podcast app).

---

Session 6: Detecting Sepsis in the Ventilated Patient

New Global Definition of Acute Respiratory Distress Syndrome (ARDS)
Michael Matthay, University of California San Francisco, United States of America

Alveolar Inflammation in ARDS
Lieuwe Bos, Amsterdam UMC, The Netherlands

Biomarkers in ARDS and Sepsis
Lorraine Ware, Vanderbilt University, United States of America

Unraveling the Enigma of Genetics and Phenotypes in Sepsis and ARDS
Carmen Barbas, University of São Paulo, Brazil

Diagnosis of Ventilator-Associated Pneumonia
Pedro Povoa, University of Lisboa, Portugal

Ventilator Support and Sepsis in Low-Middle Income Countries
Marcus Schultz, Mahidol University, Thailand

---

Sessions are released weekly on Tuesdays. The next session will be ‘Closing the Needs in Pediatric Sepsis’ on June 18, 2024.

You can already subscribe on either platform to be automatically notified once new sessions are available.

---

Full Release Schedule

• S1: Opening Session: The Renewed Global Agenda for Sepsis – Tuesday, May 7, 2024

• S2: The Need for Early Diagnosis and Treatment of Sepsis in Surgical Patients – Tuesday, May 14, 2024

• S3: Data, AI, and Predictive Modeling in Sepsis – Tuesday, May 21, 2024

• S4: How Does Hypervolemia Increase the Mortality Risk in Sepsis? – Tuesday, May 28, 2024

• S5: The Role of Biomarkers in the Early Detection of Sepsis – Tuesday, June 4, 2024

• S6: Detecting Sepsis in the Ventilated Patient – Tuesday, June 11, 2024

• S7: Closing the Needs in Pediatric Sepsis – Tuesday, June 18, 2024

• S8: Personalized Approaches to Sepsis Management – Tuesday, June 25, 2024

• S9: Challenges and Solutions for Early Recognition and Treatment of Sepsis – Tuesday, July 2, 2024

---

The Global Sepsis Alliance (GSA) is pleased to announce the successful launch of the Caribbean Sepsis and AMR Alliance, at a historic event hosted by the University of the West Indies on May 26.

The Caribbean Sepsis and AMR Alliance is established under the leadership of Trinidad and Tobago and support from co-founding members from Jamaica, Barbados, and Guyana.

GSA looks forward to making a historic breakthrough in the sepsis response in the region in close collaboration with the founding members of the Caribbean Alliance and the continued leadership of Prof. Niranjan “Tex” Kissoon - GSA President.

The Caribbean Sepsis and AMR Alliance will be the 6th official regional representation of the Global Sepsis Alliance and GSA will host the official website of the Caribbean Alliance.

“A Caribbean where Sepsis is recognized early and treated effectively, thereby reducing deaths and improving patient outcomes.”

— Vision of the Caribbean Sepsis and AMR Alliance

The launch event of the Caribbean Sepsis and AMR Alliance, hosted by the Faculty of Medicine of the University of the West Indies (UWI), St. Augustine Campus on May 26, featured a series of insightful presentations from leading scholars and public health experts.

The event commenced with opening remarks from Professor Hariharan Seetharaman - Dean of the Faculty of Medical Sciences at the University of West Indies, Professor Mala Rao - Senior Clinical Fellow of Imperial College London, and a representative of EarthMedic and EarthNurse Foundation for Planetary Health.

Dr. Satish Jankie - Lecturer of the University of the West Indies, introduced the mission and objectives of the Caribbean Sepsis and AMR Alliance. The mission of the Alliance is to reduce the incidence and mortality of sepsis through improved awareness, early detection, and effective treatment.

The current state of Antimicrobial Resistance in the Caribbean was presented by Dr. Rajiv Nagessar - Medical Officer in Microbology presenting data and strategies to mitigate this growing problem.

Dr. Darren Dookhiearam - Senior Medical Officer of the Ministry of Health of Trinidad and Tobago focused on Sepsis in the Community Setting, offering insights into the Surviving Sepsis Campaign and focused on the importance of timely detection and timely antibiotic treatment.

In his presentation, Dr. Dale Ventour – UWI Lecturer in Anaesthesia and Intensive Care explored Sepsis in the Intensive Care Unit, sharing the challenges and management of sepsis and highlighting the reasons why the establishment of the Caribbean Alliance is important.

Dr. Lisa Benjamin – UWI Lecturer in Veterinary Public Health discussed the Anti-Microbial Resistance in Veterinary Medicine, highlighting the interconnectedness of human and animal health.

The program continued with a Keynote Address by Prof. Niranjan 'Tex' Kissoon, President of the Global Sepsis Alliance. Prof. Kissoon highlighted the critical importance of the unified approach to combat Sepsis and AMR worldwide and expressed his enthusiasm for the new alliance and stronger regional collaboration for combating sepsis and improving patient outcomes.

The event concluded with closing remarks from Dr. Sandeep Maharaj, Director of the School of Pharmacy at the University of West Indies. He reiterated the significance of the Caribbean Sepsis and AMR Alliance and thanked all the participants and speakers for their valuable contributions.

The Caribbean Sepsis and AMR Alliance represents a unified effort to address the burden of sepsis in the region and is one step closer to improving healthcare across the Caribbean.

The Global Sepsis Alliance (GSA) congratulates the Caribbean Sepsis and AMR Alliance on its launch and looks forward to close collaboration with the healthcare leaders in the region to address the burden of sepsis and AMR.

---

---